DMK Pharmaceuticals Corporation

DMKPQ · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$26,199-$34,600-$35,846-$27,513
Dep. & Amort.$1,484$1,430$2,333$2,963
Deferred Tax$0$0$0$0
Stock-Based Comp.-$340$1,983$4,100$5,868
Change in WC-$1,341-$10,799$6,974-$616
Other Non-Cash$496$4,201$1,538-$587
Operating Cash Flow-$25,901-$37,785-$20,901-$19,886
Investing Activities
PP&E Inv.-$680-$1,223-$700-$2,866
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$4,164$1,506-$246$0
Investing Cash Flow$3,484$283-$946-$2,866
Financing Activities
Debt Repay.$0$1,765$3,192-$497
Stock Issued$285$51,750$18,228$13,800
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$285$420-$1,527-$1,012
Financing Cash Flow$285$53,936$19,892$12,291
Forex Effect-$8$69-$106$0
Net Chg. in Cash-$22,139$16,502-$2,062-$10,461
Supplemental Information
Beg. Cash$23,251$6,749$8,811$19,272
End Cash$1,111$23,251$6,749$8,811
Free Cash Flow-$26,581-$39,009-$21,602-$22,752